Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 391, Issue 3, pp 247–254 | Cite as

Effect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats

  • Raúl López-Arnau
  • Mario Buenrostro-Jáuregui
  • Jorge Camarasa
  • David Pubill
  • Elena Escubedo
Brief Communication

Abstract

Cathinones, such as mephedrone (Meph), are often co-abused with alcoholic drinks. In the present study, we investigated the combined effects of Meph plus ethanol (EtOH) on neurotransmitter release in the nucleus accumbens (NAc) and the medial prefrontal cortex (mPFC). A guide canula was stereotaxically implanted into either the NAc or the mPFC of male Sprague-Dawley rats. Seven days after surgery, a microdialysis probe was inserted and rats were administered saline, EtOH (1 g/kg, i.p.), Meph (25 mg/kg, s.c.), or their combination, and dialysates were collected. Serotonin (5-HT), dopamine (DA), and their metabolites (5-HIAA, DOPAC and HVA) were determined through high-pressure liquid chromatography coupled to mass spectrometry. 5-HT and DA peaked 40 min after Meph administration (with or without EtOH co-treatment) in both areas. EtOH combined with Meph increased the 5-HT release compared with the rats receiving Meph alone (85% in NAc, 65% in mPFC), although the overall change in the area under the curve only reached statistical significance in the NAc. In mPFC, the increased release of 5-HT lasted longer in the combination than that in the Meph group. Moreover, EtOH potentiated the psychostimulant effect of Meph measured as a locomotor activity. Given that both 5-HT and DA are also related with reward and impulsivity, the observed effects point to an increased risk of abuse liability when combining Meph with EtOH compared with consuming these drugs alone.

Keywords

Mephedrone Ethanol Cathinones Microdialysis Drug polyabuse Bath salts 

Abbreviations

5-HIAA

5-Hydroxyindoleacetic acid

5-HT

Serotonin

DA

Dopamine

DOPAC

3,4-Dihydroxyphenylacetic acid

EtOH

Alcohol/ethanol

LC-MS

Liquid chromatography-mass spectrometry

MDMA

3,4-Methylenedioxymethamphetamine

Meph

Mephedrone

mPFC

Medial prefrontal cortex

NAc

Nucleus accumbens

Notes

Compliance with ethical standards

All animal care and experimental protocols in this study complied with the guidelines of the European Community Council (86/609/ECC) and were approved by the Animal Ethics Committee of the University of Barcelona. All efforts were made to minimize animal suffering and to reduce the number of animals used.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF, Brandt SD, Rothman RB, Ruoho AE, Cozzi NV (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37(5):1192–1203.  https://doi.org/10.1038/npp.2011.304 CrossRefPubMedGoogle Scholar
  2. Ben-Hamida S, Tracqui A, de Vasconcelos AP, Szwarc E, Lazarus C, Kelche C, Jones BC, Cassel JC (2009) Ethanol increases the distribution of MDMA to the rat brain: possible implications in the ethanol-induced potentiation of the psychostimulant effects of MDMA. Int J Neuropsychopharmacol 12(3-4):749–759.  https://doi.org/10.1159/000253554 CrossRefGoogle Scholar
  3. Bloom F, Lad P, Pittman Q, Rogers J (1982) Blood alcohol levels in rats: non-uniform yields from intraperitoneal doses based on body weight. Br J Pharmacol 75(1):251–254.  https://doi.org/10.1111/j.1476-5381.1982.tb08780.x CrossRefPubMedPubMedCentralGoogle Scholar
  4. Brabant C, Guarnieri DJ, Quertemont E (2014) Stimulant and motivational effects of alcohol: lessons from rodent and primate models. Pharmacol Biochem Behav 122:37–52.  https://doi.org/10.1016/j.pbb.2014.03.006 CrossRefPubMedGoogle Scholar
  5. Brodie MS, Trifunović RD, Shefner SA (1995) Serotonin potentiates ethanol-induced excitation of ventral tegmental area neurons in brain slices from three different rat strains. J Pharmacol Exp Ther 273(3):1139–1146PubMedGoogle Scholar
  6. Brunt TM, Koeter MW, Niesink RJ, van den Brink W (2012) Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology 220(4):751–762.  https://doi.org/10.1007/s00213-011-2529-4 CrossRefPubMedGoogle Scholar
  7. Cassel JC, Jeltsch H, Koenig J, Jones BC (2004) Locomotor and pyretic effects of MDMA-ethanol associations in rats. Alcohol 34(2-3):285–289.  https://doi.org/10.1016/j.alcohol.2004.09.003 CrossRefPubMedGoogle Scholar
  8. Cassel JC, Riegert C, Rutz S, Koenig J, Rothmaier K, Cosquer B, Lazarus C, Birthelmer A, Jeltsch H, Jones BC, Jackisch R (2005) Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat. Neuropsychopharmacology 30(10):1870–1882.  https://doi.org/10.1038/sj.npp.1300714 CrossRefPubMedGoogle Scholar
  9. Ciudad-Roberts A, Camarasa J, Ciudad CJ, Pubill D, Escubedo E (2015) Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition. Br J Pharmacol 172:4970–4984.  https://doi.org/10.1111/bph.13266. CrossRefPubMedPubMedCentralGoogle Scholar
  10. Ciudad-Roberts A, Duart-Castells L, Camarasa J, Pubill D, Escubedo E (2016) The combination of ethanol with mephedrone increases the signs of neurotoxicity and impairs neurogenesis and learning in adolescent CD-1 mice. Toxicol Appl Pharmacol 293:10–20.  https://doi.org/10.1016/j.taap.2015.12.019. CrossRefPubMedGoogle Scholar
  11. Clapp P, Bhave SV, Hoffman PL (2008) How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. Alcohol Res Health 31(4):310–339PubMedPubMedCentralGoogle Scholar
  12. Dalley JW, Theobald DE, Eagle DM, Passetti F, Robbins TW (2002) Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology 26(6):716–728.  https://doi.org/10.1016/S0893-133X(01)00412-2 CrossRefPubMedGoogle Scholar
  13. Daws LC, Montañez S, Munn JL, Owens WA, Baganz NL, Boyce-Rustay JM, Millstein RA, Wiedholz LM, Murphy DL, Holmes A (2006) Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. J Neurosci 26(24):6431–6438.  https://doi.org/10.1523/JNEUROSCI.4050-05.2006 CrossRefPubMedGoogle Scholar
  14. Elliott S, Evans J (2014) A 3-year review of new psychoactive substances in casework. Forensic Sci Int 243:55–60.  https://doi.org/10.1016/j.forsciint.2014.04.017 CrossRefPubMedGoogle Scholar
  15. Golembiowska K, Jurczak A, Kaminska K, Noworyta-Sokolowska K, Gorska A (2016) Effect of some psychoactive drugs used as “legal highs” on brain neurotransmitters. Neurotox Res 29:394–407.  https://doi.org/10.1007/s12640-015-9569-1. CrossRefPubMedGoogle Scholar
  16. Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, Andrenyak DM, Vieira-Brock PL, German CL, Conrad KM, Hoonakker AJ, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE (2011) 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339(2):530–536.  https://doi.org/10.1124/jpet.111.184119 CrossRefPubMedPubMedCentralGoogle Scholar
  17. Hammerslag LR, Waldman AJ, Gulley JM (2014) Effects of amphetamine exposure in adolescence or young adulthood on inhibitory control in adult male and female rats. Behav Brain Res 263:22–33.  https://doi.org/10.1016/j.bbr.2014.01.015 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Imperato A, Di Chiara G (1986) Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239(1):219–228PubMedGoogle Scholar
  19. Jones BC, Ben-Hamida S, de Vasconcelos AP, Kelche C, Lazarus C, Jackisch R, Cassel JC (2010) Effects of ethanol and ecstasy on conditioned place preference in the rat. J Psychopharmacol 24(2):275–279.  https://doi.org/10.1177/0269881109102775 CrossRefPubMedGoogle Scholar
  20. Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F, Yoshitake T (2011) Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol 164(8):1949–1958.  https://doi.org/10.1111/j.1476-5381.2011.01499.x CrossRefPubMedPubMedCentralGoogle Scholar
  21. López-Arnau R, Martínez-Clemente J, Pubill D, Escubedo E, Camarasa J (2012) Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol 167:407–420.  https://doi.org/10.1111/j.1476-5381.2012.01998.x. CrossRefPubMedPubMedCentralGoogle Scholar
  22. López-Arnau R, Martínez-Clemente J, Rodrigo T, Pubill D, Camarasa J, Escubedo E (2015) Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone. Toxicol Appl Pharmacol 286(1):27–35.  https://doi.org/10.1016/j.taap.2015.03.015 CrossRefPubMedGoogle Scholar
  23. Martínez-Clemente J, López-Arnau R, Carbó M, Pubill D, Camarasa J, Escubedo E (2013) Mephedrone pharmacokinetics after intravenous and oral administration in rats: relation to pharmacodynamics. Psychopharmacology 230(2):295–306.  https://doi.org/10.1007/s00213-013-3108-7 CrossRefGoogle Scholar
  24. Mitchell JM, O'Neil JP, Janabi M, Marks SM, Jagust WJ, Fields HL (2012) Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Sci Transl Med 4(116):116ra6.  https://doi.org/10.1126/scitranslmed.3002902 CrossRefPubMedGoogle Scholar
  25. Mohamed WM, Ben Hamida S, de Vasconcelos AP, Cassel JC, Jones BC (2009) Interactions between 3,4-methylenedioxymethamphetamine and ethanol in humans and rodents. Neuropsychobiology 60(3-4):188–194.  https://doi.org/10.1159/000253554 CrossRefPubMedGoogle Scholar
  26. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2(2):119–128.  https://doi.org/10.1038/35053570 CrossRefPubMedGoogle Scholar
  27. O’Neill C, McElrath K (2012) Simultaneous use of mephedrone and alcohol: a qualitative study of users’ experiences. J Addict Res Ther S9-001(02):1–5.  https://doi.org/10.4172/2155-6105.S9-001 Google Scholar
  28. Riegert C, Wedekind F, Ben Hamida S, Rutz S, Rothmaier AK, Jones BC, Cassel JC, Jackisch R (2008) Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain. Int J Neuropsychopharmacol 11(06):743–763.  https://doi.org/10.1017/S1461145708008481 CrossRefPubMedGoogle Scholar
  29. Siggins GR, Roberto M, Nie Z (2005) The tipsy terminal: presynaptic effects of ethanol. Pharmacol Ther 107:80–98CrossRefPubMedGoogle Scholar
  30. Wright MJ Jr, Angrish D, Aarde SM, Barlow DJ, Buczynski MW, Creehan KM, Vandewater SA, Parsons LH, Houseknecht KL, Dickerson TJ, Taffe MA (2012) Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats. PLoS One 7(8):e44652.  https://doi.org/10.1371/journal.pone.0044652 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pharmacology, Toxicology and Therapeutic Chemistry, Pharmacology Section and Institute of Biomedicine (IBUB), Faculty of PharmacyUniversity of BarcelonaBarcelonaSpain
  2. 2.Neuroscience Laboratory, Department of PsychologyUniversidad IberoamericanaMexico CityMexico

Personalised recommendations